Insider Trading History of Mosbrooker Eric

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Mosbrooker Eric since 2017. This trader's CIK number is 1715283. At the time of last reporting, Mosbrooker Eric was the Chief Commercial Officer of Avidity Biosciences, Inc.. (stock ticker symbol RNA). Also see all insider trading activities at Avidity Biosciences, Inc..

Note that in the past Mosbrooker Eric also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Avidity Biosciences, Inc. (RNA) by Mosbrooker Eric

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 RNA 0 $0 137,369 $6,061,518 131,249 $1,187,803

Yearly summary of insider trading at Horizon Therapeutics Public Ltd Co (HZNP) by Mosbrooker Eric

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 HZNP 0 $0 0 $0 4,435 $0


Insider trading activities at 2 companies by Mosbrooker Eric:

1. Avidity Biosciences, Inc. (RNA)

2. Horizon Therapeutics Public Ltd Co (HZNP)

Table 1. Insider trading of Avidity Biosciences, Inc. (RNA) by Mosbrooker Eric

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-10-03 RNA Option Ex 6,562 9.05 59,386
2025-10-03 RNA Sale 6,562 45.38 297,770
2025-08-06 RNA Option Ex 124,687 9.05 1,128,417
2025-08-06 RNA Sale 130,807 44.06 5,763,748

Table 2. Insider trading of Horizon Therapeutics Public Ltd Co (HZNP) by Mosbrooker Eric

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-11-01 HZNP Option Ex 4,435 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mosbrooker Eric (Chief Commercial Officer of Avidity Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.